171 related articles for article (PubMed ID: 17099780)
1. [Diagnostic imaging in lung cancer].
Palkó A
Magy Onkol; 2006; 50(3):217-21. PubMed ID: 17099780
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
3. Imaging in lung cancer.
Sarinas PS; Chitkara RK; Rizk NW; Segall GM; Stark P
Curr Opin Pulm Med; 1996 Jul; 2(4):263-70. PubMed ID: 9363150
[TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
5. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
6. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
7. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.
De Wever W; Vankan Y; Stroobants S; Verschakelen J
Eur Respir J; 2007 May; 29(5):995-1002. PubMed ID: 17331966
[TBL] [Abstract][Full Text] [Related]
8. CT, positron emission tomography, and MRI in staging lung cancer.
Erasmus JJ; Sabloff BS
Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
[TBL] [Abstract][Full Text] [Related]
9. How to choose PET-CT or CT in the diagnosis and staging of lung cancer. Practical experience in China.
Jiang T; Zheng X; Tao X; Liu H; Liu S
Nuklearmedizin; 2010; 49(1):28-34. PubMed ID: 19847358
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging in lung cancer.
Harders SW; Balyasnikowa S; Fischer BM
Clin Physiol Funct Imaging; 2014 Sep; 34(5):340-55. PubMed ID: 24289258
[TBL] [Abstract][Full Text] [Related]
11. Contribution of magnetic resonance imaging in lung cancer imaging.
Khalil A; Majlath M; Gounant V; Hess A; Laissy JP; Debray MP
Diagn Interv Imaging; 2016 Oct; 97(10):991-1002. PubMed ID: 27693089
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Qu X; Huang X; Yan W; Wu L; Dai K
Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
[TBL] [Abstract][Full Text] [Related]
13. TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT.
Huellner MW; de Galiza Barbosa F; Husmann L; Pietsch CM; Mader CE; Burger IA; Stolzmann P; Delso G; Frauenfelder T; von Schulthess GK; Veit-Haibach P
J Nucl Med; 2016 Jan; 57(1):21-6. PubMed ID: 26471696
[TBL] [Abstract][Full Text] [Related]
14. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
15. [The role of PET in lung cancer staging].
Gärtner FC; Buermann J; Skowasch D; Biersack HJ; Essler M
Dtsch Med Wochenschr; 2015 Apr; 140(9):679-83. PubMed ID: 25924049
[TBL] [Abstract][Full Text] [Related]
16. Imaging of thoracic cavity tumors.
Hayes SA; Plodkowski AJ; Ginsberg MS
Surg Oncol Clin N Am; 2014 Oct; 23(4):709-33. PubMed ID: 25246047
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
18. [New trends and novel possibilities in the radiodiagnosis of lung cancer].
Monostori Z
Magy Onkol; 2015 Mar; 59(1):37-43. PubMed ID: 25763912
[TBL] [Abstract][Full Text] [Related]
19. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]